Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

306 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2029-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis

NCT00506337

Pancreatitis, Acute Necrotizing

UNKNOWN PHASE2/PHASE3

Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage

NCT00815737

Lung Infection Cerebral Hemorrhage Pneumonia

UNKNOWN PHASE2/PHASE3

RCT for the Chinese Medicine in Treating Hypercholesterolemia

NCT06700408

Hypercholesterolemia

NOT_YET_RECRUITING PHASE2

The Clinical Study of Acute Pancreatitis Treated by TongFuSan

NCT02204189

Acute Pancreatitis

UNKNOWN PHASE1/PHASE2

Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms

NCT01844050

Type 2 Diabetes Mellitus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DDC(Dachaihu decoction compound) Group

Treated with Dachaihu decoction compound and regular therapies

Group Type EXPERIMENTAL

Dachaihu decoction compound

Intervention Type COMBINATION_PRODUCT

Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.

Regular therapies

Intervention Type COMBINATION_PRODUCT

Regular therapies, such as fluid therapy, for acute pancreatitis

RSM(rhubarb single medicine) Group

Treated with rhubarb single medicine and regular therapies

Group Type ACTIVE_COMPARATOR

Rhubarb single medicine

Intervention Type DRUG

Rhubarb single medicine

Regular therapies

Intervention Type COMBINATION_PRODUCT

Regular therapies, such as fluid therapy, for acute pancreatitis

N Group

Treated with regular therapies and without traditional Chinese medicine

Group Type OTHER

Regular therapies

Intervention Type COMBINATION_PRODUCT

Regular therapies, such as fluid therapy, for acute pancreatitis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dachaihu decoction compound

Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.

Intervention Type COMBINATION_PRODUCT

Rhubarb single medicine

Intervention Type DRUG

Regular therapies

Regular therapies, such as fluid therapy, for acute pancreatitis

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 18 to 65 years old
* Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48 hours of onset
* Consent of the subjects, who sign the informed consent form

Exclusion Criteria

* Women who are pregnant or breastfeeding
* Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation, purulent cholangitis, etc.
* Patients with a history of severe heart, liver, kidney and other important organ diseases
* Patients with mental illness and malignant tumors
* People who have allergies, or are allergic to a certain drug ingredient

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No